hr:

TScan Therapeutics Announces Positive Updated Data from the ALLOHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition

December 06, 2025 17:30 ET  | Source: TScan Therapeutics, Inc. Treatment arm continues to demonstrate favorable relapse-free survival (HR=0.50; p=0.23)…

3 weeks ago

Joget Unlocks Autonomous Productivity Across HR, Procurement, Customer Service, and Supply Chain with No-Code AI Agent Builder

Joget AI Agent Builder enables teams across every department to create goal-driven agents that execute autonomously, yet remain governed by…

2 months ago